|Bid||0.00 x 800|
|Ask||0.00 x 1200|
|Day's Range||54.90 - 56.10|
|52 Week Range||51.34 - 74.98|
|Beta (3Y Monthly)||0.85|
|PE Ratio (TTM)||16.57|
|Earnings Date||Aug 1, 2019|
|Forward Dividend & Yield||2.24 (4.06%)|
|1y Target Est||58.12|
MarketWatch Columnist Brett Arends discusses why he says Kellogg's 'MorningStar' brand could take on Beyond Meat in the alternative meat space, and the outlook for the 'fake meat' brand amid Beyond Meat's success. He joins Yahoo Finance's Zack Guzman and Brian Cheung, along with Ian Wishingrad, ‘BigEyedWish’ founder, to discuss.
The perfect bite-sized snack offers a lunch bag solution with nutrients kids need and a taste they'll love BATTLE CREEK, Mich. , July 16, 2019 /PRNewswire/ -- Kids are the toughest food critics around. ...
The staples sector has gained 19.9% this year, edging out most other sectors. The stocks appear to be rising almost entirely due to multiple expansion, rather than forecast earnings growth.
It's not terribly easy out there for income investors at the moment. Dividend stocks to buy are tough to find. Equity markets are at all-time highs, meaning valuations are stretched -- and dividend yields are lower. Treasury yields have fallen amid expectations for a Fed rate cut: getting income from bonds is no easy task, either.Many longtime dividend growth stalwarts -- think McDonald's (NYSE:MCD) or Procter & Gamble (NYSE:PG) -- trade at all time highs. Those that aren't seem to be struggling, with the likes of General Electric (NYSE:GE), Kraft Heinz (NASDAQ:KHC), and Anheuser-Busch (NYSE:BUD) all cutting their dividends in recent years. Finding the middle ground -- an attractive valuation combined with a solid business -- is exceedingly difficult right now.Given lower commissions, investors can sell off small parts of their holdings for income -- most of which should have appreciated nicely in this decade-long bull market. But income investors usually are looking for "set it and forget it" dividend stocks to buy, not constant portfolio trading.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Sell for an Economic Slowdown These 10 stocks don't quite qualify as "set it and forget it" plays. All have some degree of risk. But the risks seem worth taking for the potential rewards, which include near-term income, longer-term growth, and potential capital appreciation. As such, investors should take at least a long look at these 10 dividend plays. Broadcom (AVGO)Dividend Yield: 3.8%Broadcom (NASDAQ:AVGO) requires quite a bit of trust in management. The semiconductor giant has been built through acquisitions. As of late, AVGO has started moving away from chips and into software.Last year, the company acquired CA Technologies, an enterprise software play with a big presence in mainframe applications. Broadcom is now reportedly in talks to take over security play Symantec (NASDAQ:SYMC).Investors haven't particularly liked either deal. AVGO stock fell on the news of the CA deal. It has slipped again as reports of the Symantec acquisition leaked. But CEO Hock Tan certainly deserves the benefit of the doubt at this point. And the decline after the CA announcement, in particular, proved a buying opportunity: before the recent pullback, AVGO shares had risen some 50% in roughly a year.AVGO may not provide that type of return over the next year -- but there's still a nice bull case here on another merger-related dip. AVGO yields 3.8%. The Symantec deal will add to the company's significant free cash flow, which keeps that yield secure. Diversification in the existing chip business limits the cyclical impact on earnings -- and AVGO shares. Investors do have to trust Hock Tan at this point -- but history shows they probably should. Kellogg (K)Dividend Yield: 4%On its face, Kellogg (NYSE:K) seems like a safe value play for income investors. Shares of the iconic American company trade for just 13x 2020 EPS estimates. Kellogg's dividend yields just over 4%. K historically has been a defensive stock, providing protection if the broader economy stumbles.But K stock is actually dangerous at this point. It's one of many consumer stocks struggling to adapt to a new reality, as I detailed last year. Grocers like Kroger (NYSE:KR) are looking to private-label and own brands to protect their thin margins. Cereal demand is falling. As a result, Kellogg's earnings are heading in the wrong direction.Revenue is guided to increase just 1-2% this year excluding the impact of currency and the company's divestiture of several smaller brands. Adjusted operating income, on the same basis, is expected to be roughly flat. Guidance suggests overall non-GAAP earnings per share will decline more than 10% year-over-year.In other words, Kellogg isn't a defensive stock at this point. It's a turnaround play. And like with KHC and BUD, that creates downside risk if the turnaround stumbles.For investors who understand the risks, however, K stock is intriguing. As Barron's detailed just last week, the company's Morningstar Farms business seems notably undervalued. It's larger by revenue than Beyond Meat (NASDAQ:BYND), which has soared to a $10 billion market cap. Kellogg (including debt) is valued at just $28 billion; a sale or IPO of Morningstar could unlock significant value. * 7 Retail Stocks to Buy for the Second Half of 2019 Again, this is not the traditional, low-risk, dividend stock it used to be. But if Kellogg can jumpstart growth and monetize Morningstar, K stock could have enormous upside ahead. Gap (GPS)Dividend Yield: 5.4%The case for Gap (NYSE:GPS), particularly with the stock threatening a seven-year low, is that investors are missing the real story here. As I wrote back in November, Gap stock isn't about its Gap brand; it's about Old Navy, which likely generates somewhere in the range of three-quarters of operating profit.With Gap planning to spin off Old Navy later this year, that value might be unlocked. In the meantime, GPS stock yields 5.4%, a figure that might rise after the split.There are risks here, to be sure. Luke Lango called GPS stock one of the six worst in the S&P 500 in the first half -- and he's not wrong. GPS shares have plunged.Old Navy's sales performance in the last two quarters have not been particularly impressive. Sales for the Gap brand continue to decline. In fact, analysts asked repeatedly on the Q1 conference call if the spin-off would still move forward: there's a risk that Gap and Banana Republic might not be enough to support a standalone company, even with growth from athleisure concept Athleta.Even a weaker-than-expected Old Navy still likely supports the entire valuation of GPS stock at the moment. The balance sheet is in good shape, and free cash flow continues to be impressive. Income investors can get yield now -- and if all goes well, by next year own growth at Old Navy and income from the company's other brands. SL Green (SLG)Dividend Yield: 4.2%REITs (real estate investment trusts) like SL Green (NYSE:SLG) long have been income investors favorites. REITs allow for diversified exposure to real estate. They offer tax benefits as well: as long as they pay out 90% of taxable income, they pay no tax at the corporate level.In an environment where 10-year Treasury bonds are yielding barely 2%, however, investors looking for dividend stocks to buy have the same difficulty in REITs as in the rest of the market. High-yield REITs generally have some flaws; most notably, even the best retail REITs like Simon Property Group (NYSE:SPG) and Macerich (NYSE:MAC) have struggled amid long-term concerns about demand. The more attractive plays, meanwhile, have been bid up as investors look for lower-risk yield.SL Green might be a nice middle ground. The stock has struggled for years now; in fact, it touched a five-year low late last year. Worries about the health of New York City real estate seem to be the culprit. Weakness in the company's suburban assets hasn't helped, either. * 10 Best Stocks for 2019: A Volatile First Half But SL Green largely has exited the suburban business, refocusing on Manhattan. The dividend continues to rise. And longer-term, NYC still seems an attractive real estate market. With a 4.2% dividend, SLG provides attractive income. At 12x FFO (funds from operations, a typical REIT metric), it could provide upside as well if sentiment toward Manhattan real estate improves. Avista (AVA)Dividend Yield: 3.48%Utility stocks like Avista (NYSE:AVA) are another common area of focus for income investors. And like REITs, valuation is a question mark: the Utilities SPDR (NYSEARCA:XLU) is up 16% over the past year, a big move for a traditionally low-volatility sector.But AVA looks like one of the more attractive picks in the industry at the moment. The stock plunged late last year after a potential acquisition by Canada's Hydro One (OTCMKTS:HRNNF) was called off. Slowly but surely, however, dip-buyers have entered -- and there could be more buying ahead.Avista provides a solid 3.48% dividend yield. Its markets in Washington State, Idaho, and Montana are seeing strong population growth. Valuation is reasonable, and AVA still sits back at 2016 levels.It's likely the Hydro One deal -- announced in 2017 -- led to some dislocation among Hydro One's investor base. If that's the case, there's an opportunity for AVA to catch up to the rest of its sector as income investors return to the story. International Game Technology (IGT)Dividend Yield: 6%The risks facing International Game Technology (NYSE:IGT) are almost self-evident. Gaming stocks traditionally struggle in recessions. Suppliers like IGT generally aren't hit quite as hard, and the company's lottery business should provide support if the economy turns. But there is a decent amount of cyclical risk here.A good chunk of the company's profit comes from Italy, where economic growth has been stagnant and political risk seems high. The U.S. slot business has lost market share to smaller operators like Aristocrat Leisure (OTCMKTS:ARLUF) and PlayAGS (NYSE:AGS). On top of all that, IGT has nearly $7 billion in debt. The 6% yield here is attractive -- but on its own not reason enough to buy IGT stock.That said, there are reasons to buy, and in fact I personally own IGT shares. Free cash flow should ramp in the next two years, as the company moves past upfront payments required to maintain its concessions in Italy. The lottery business throws off cash as well. Debt should come down, and the U.S. slot business is showing signs of improvement. * 7 A-Rated Stocks to Buy for the Rest of 2019 The rewards here are enormous as well. As I wrote last month, Wall Street sees huge upside for IGT. The average target price near $21 is 56% higher than IGT's current price. If IGT can get the U.S. business back on track and use the cash flow from Italy to pay down debt, its stock could have a big move ahead. State Street (STT)Dividend Yield: 4%State Street (NYSE:STT) is a clear "value trap or value play?" argument at the moment. For the last 18 months, investors have made their thoughts clear: STT stock has dropped by roughly 50%.And State Street is fighting headwinds. The company rolled out the first ETF -- the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) -- but has since been passed by Vanguard and BlackRock (NYSE:BLK) in that key business. The same shift to passive investing driving ETF growth has pressured the company's asset management business. In Q1, fee revenue declined 4% year-over-year; earnings per share declined 27%.Cost-cutting simply hasn't done quite enough to protect margins, leading to the recent pressure on STT stock. But at this point, there's a question as to whether the sell-off simply has gone too far. STT stock is quite cheap, at less than 8x 2020 EPS estimates. Price-to-book has dipped below 1x for the first time in over five years.Meanwhile, a recent dividend hike moves the yield near 4%, and STT will repurchase $2 billion worth of stock as well. State Street has to find a way to manage pressure on its custody and management businesses -- but if it can, there's potential for a big reversal in STT stock. CVS Health (CVS)Dividend Yield: 3.6%Source: Shutterstock CVS Health (NYSE:CVS) has had a rough go of it in recent years. In March, CVS stock touched its lowest level in almost six years, and it has re-tested those lows several times since. The acquisition of Aetna is under review even after it closed. Lower reimbursement rates and reduced savings on generic drugs are pressuring the entire pharmacy sector: rivals Walgreens (NASDAQ:WBA) and Rite Aid (NYSE:RAD) are struggling as well.But as I wrote this week, to at least some extent all of those headwinds seem priced in. CVS stock trades at historically low multiples. There are still benefits to come from the company's efforts to change healthcare, and the integration of Aetna with its existing pharmacy business. * 7 Retail Stocks to Buy That Are Down in 2019 The headwinds are real, and the sell-off in CVS stock does make some sense. But this remains an attractive business that is now priced for steady declines going forward. It will take little in the way of an upside surprise for CVS to outperform expectations -- and for CVS stock to claw back at least some of its recent losses. BP (BP)Dividend Yield: 6%For BP (NYSE:BP), the case is reasonably simple. BP is the integrated energy company with the best dividend yield, which currently nears 6%. With liabilities relating to the Deepwater Horizon tragedy finally behind the company, cash flow and earnings will improve as BP gets back to "normal."That's a case I've made for some eighteen months now -- and it still holds. Oil price movements might seem a risk -- but BP's downstream businesses benefit from lower crude prices, which mitigates that effect somewhat. In this market, BP stock might even be considered among the safer plays out there, as counterintuitive as that sounds. For a 6% yield the modest risks here seem worth taking. Bristol-Myers Squibb (BMY)Dividend Yield: 3.6%Pharmaceutical companies, too, used to be a safe haven for income investors. They generally offered dividend yields of at least 2% -- and protection from market and economic downturns. That's no longer the case, however -- which highlights the potential risk in Bristol-Myers Squibb (NYSE:BMY).U.S. companies, in particular, have struggled to find blockbusters. As a result, patent expirations on key product lead companies to search for growth however it can be found. For Bristol-Myers Squibb, products like Orencia (which treats rheumatoid arthritis) and blood thinner Eliquis are losing their protection shortly. And so the company went and acquired biotechnology major Celgene (NASDAQ:CELG).Unfortunately for BMY stock, investors hated the deal. BMY shares dropped 13%. They liked it less when Bristol-Myers announced last month that it would divest psoriasis treatment Otezla as required by regulators. BMY once again threatened a six-year low.But at this point, BMY is starting to look attractive. Even if the company overpaid for Celgene, to some extent that's baked into the stock price. The dividend yield now sits at 3.6% -- and could rise once the acquisition is completed. A 10x forward P/E multiple will come down as well.Pharma stocks are riskier than they used to be -- especially for those using debt to drive growth. Mallinckrodt (NYSE:MNK) is a good example of how pharmaceutical M&A can go terribly wrong. But Bristol-Myers Squibb's diversified base and long history suggest the downside shouldn't be that steep. And as Celgene comes on board and growth returns, investors might again start focusing on the potential rewards.As of this writing, Vince Martin is long shares of Gap Inc. and International Game Technology. He has no positions in any other securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell for an Economic Slowdown * 7 Marijuana Penny Stocks That I May Buy * 7 of The Best Schwab ETFs for Low Fees The post 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond appeared first on InvestorPlace.
Kellogg (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Kellogg's New York City Café celebrates 3rd birthday with cereal-themed party, including new Froot Loops™ Birthday Cake flavor BATTLE CREEK, Mich. , July 10, 2019 /PRNewswire/ -- Cereal isn't just for ...
Atlanta's fast-growing medical marijuana startup has added another splashy name to its C-Suite. Surterra Wellness said Tuesday it expanded its senior leadership team by hiring former Kellog Company (NYSE: K) executive Fareed Khan as its chief financial officer. In this role, Khan will lead Surterra's finance group and be responsible for corporate finance, investor relations, tax and shared services activities.
Cannabis company Surterra Wellness on Tuesday announced the appointment of Fareed Khan as its new Chief Financial Officer. Khan will replace James Whitcomb, who has been the company's CFO since its launch ...
MarketWatch columnist Brett Arends discusses why he says Kellogg's 'MorningStar' brand could take on Beyond Meat in the alternative meat space, and the outlook for the 'fake meat' brand amid Beyond Meat's success.
Netflix's Stranger Things 3 brought back the nostalgia of 1980s pop culture and boosted the streaming service as well as brands that changed consumer habits.
Kellogg Co NYSE:KView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for K with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $8.79 billion over the last one-month into ETFs that hold K are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. K credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Tuesday ahead of the opening bell, PepsiCo will be one of the first major companies to deliver second-quarter financial results.
BATTLE CREEK, Mich. , July 8, 2019 /PRNewswire/ -- Kellogg Company (NYSE: K) plans to issue its 2019 second quarter financial results at approximately 8:00 am EDT on Thursday , August 1, 2019. The following ...
Stockholders in Kellogg have been crying into their Corn Flakes for years. Kellogg stock (K) which peaked at $87 in July 2016, is down to under $54 and recently touched a seven-year low after falling 6.4% just since the start of this year through Monday.
Like many would have expected, Wednesday's half-day trading session was relatively mellow, with stocks drifting higher throughout the day. The markets will be closed on Thursday for the Fourth of July and will reopen for a regular session on Friday. Also, don't forget we have a jobs report that day, too. Let's take a look at a few top stock trades based on Wednesday's action. Top Stock Trades for Tomorrow 1: Symantec Click to EnlargeShares of Symantec (NASDAQ:SYMC) are surging more than 13% on Wednesday on reports that Broadcom (NASDAQ:AVGO) is working on a deal to acquire the company. AVGO is big into the M&A game, given its immense cash flow. With SYMC's slow-and-steady growth and low valuation, it's a reasonable target for AVGO, even though investors are showing some disapproval, sending shares down by about 4% on the day.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor SYMC, the rally is sending shares through that vital $24.50 area. That's great news for the stock and if it didn't have a potential buyout cap tied to it, this would be a must-buy breakout. * 7 of the Best SPDR ETFs -- Besides SPY and GLD But either AVGO is buying the company and there's limited upside left or it's not buying it and shares will plunge from here. Top Stock Trades for Tomorrow 2: Broadcom Click to EnlargeWith Broadcom stock, though, there's a decent risk/reward setting up. However, I should mention that this one is tricky. I own AVGO for its low valuation and strong free cash flow, and bought it when its dividend yield was north of 4%. Essentially, I'm in it for the yield and solid fundamentals.From a pure trading perspective though, there may be better candidates. That's because the trade-war noise, conflicting reports on the restriction lifts on Huawei and now the potential acquisition of SYMC add more volatility into the stock. Just look at the last few days of action.In any regard, the stock is holding its 50-day moving average, while its 20-day is trending higher and just below current levels. Further, the $280 level has been notable in the past. If AVGO can hold $280 and its 20-day moving average, bulls can try to ride it back to $300.If it fails, see if the 200-day acts as support. Investors going long on this setup are risking about $4 per share and are looking for $10 to $20 in potential upside. Top Stock Trades for Tomorrow 3: Kellogg Click to EnlargeNot usually a big trading candidate, Kellogg (NYSE:K) is making waves with its almost 7% rally. The stock's up on a Barron's piece highlighting its fake-meat potential. Given the rise in Beyond Meat (NASDAQ:BYND), it's no wonder K is catching such a boost.The rally has sent shares surging through its 20-day and 50-day moving averages, with some longs looking for a potential squeeze up to the $58 area. This level has been notable in the past, while the 200-day moving average sits just above at $58.77.So what now?Investors can either wait for a pullback, perhaps down to its 50-day moving average. Otherwise, let's watch for a breakout over the $57.50 to $58 area. Top Stock Trades for Tomorrow 4: Canopy Growth Click to EnlargeThe good new or the bad news for Canopy Growth (NYSE:CGC) -- which do you want first? And no, the CEO's apparent firing isn't the bad news.The bad news, which we'll do first, is that CGC continues to put in a series of lower highs and lower lows. This is a bearish technical setup. The good news? CGC keeps attracting buyers in the upper-$30s and despite falling some 8% in pre-market trading, shares are actually positive on the day.Take it for what you will though, as this one tends to be volatile. Top Stock Trades for Tomorrow 5: Bank of America Click to EnlargeOh how I want to give Bank of America (NYSE:BAC) the benefit of the doubt. But the bank stocks just can't seem to catch a bid, even after the group gave a huge increase to their buybacks and dividends.Some investors ignore the chart's wicks and go by closing prices, which suggests BAC broke out this week (over that blue line). Others do use the wicks and say BAC failed to breakout (still under its purple line).What's this "benefit of the doubt" talk? After such positive news, I want to say BAC stock is in breakout mode. For me, a strong stock gets the benefit of the doubt (it broke out), while weak stocks do not (prove it to me and re-breakout again). Unfortunately, BAC does not get the benefit of the doubt treatment from me. * 10 Stocks That Should Be Every Young Investor's First Choice For BAC, I need to see shares over $29.50 to feel confident. Otherwise, I want to see a pullback to the $28.30 to $28.50 area hold for a dip-buy.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long AVGO. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Should Be Every Young Investor's First Choice * 5 IPO Stocks to Buy -- According to Wall Street Analysts * The Top 10 Best Sectors in the Market for 2019 The post 5 Top Stock Trades for Friday: AVGO, BAC, CGC, K, SYMC appeared first on InvestorPlace.
Kellogg news for Wednesday about its plant-based meat offerings have K stock heading higher.Source: Shutterstock Kellogg (NYSE:K) is the owner of MorningStar Farms, which is a brand that deal is fake meat. It's origins date back to the 1970s and is the largest maker of plant-based meat. This includes both chicken and burgers.There's a major buzz around fake meat right now that could have Kellogg cashing in on this brand. Other companies, such as Beyond Meat (NASDAQ:BYND) and Impossible Burger, are seeing growth as their business picks up in the raising market.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe real surprise from the Kellogg news is that the company isn't looking to capitalize on this. There are no known plans from the company to hold an IPO for MorningStar Farms or attempt to revitalize the brand.High estimates claim that MorningStar Farms is pulling in revenue of roughly $450 million a year. On the low end that may be closer to $300 million. Even at these values, that's still above revenue estimates of $210 million for Beyond Meat in 2019, reports MarketWatch. * 10 Stocks That Should Be Every Young Investor's First Choice All of this talk about Kellogg potentially having an incredible value hidden among its brands has K stock on its way up today. The stock was up 6% as of Wednesday morning, but is down 5% since the start of the year. It also hasn't been performing well for the last few years. It peaked at $85.99 back in July 2019, but was trading at $53.31 when markets closed on Tuesday. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Should Be Every Young Investor's First Choice * 5 IPO Stocks to Buy -- According to Wall Street Analysts * The Top 10 Best Sectors in the Market for 2019 As of this writing, William White did not hold a position in any of the aforementioned securities.The post Kellogg News: K Stock Surges on Plant-Based Meat Chatter appeared first on InvestorPlace.
Kellogg (NYSE: K ) shares rallied after a MarketWatch columnist shared why he thinks, “Kellogg is sitting on a 'fake meat' gold mine bigger than Beyond Meat,” adding that MorningStar Grillers’ vegetarian ...
There’s a sudden Wall Street mania for so-called fake meat burgers. Kellogg already owns the largest fake meat operation in the country in MorningStar Farms. Where’s its IPO?
General Mills (GIS) released its fourth-quarter fiscal 2019 results on June 26. Its performance was mixed, with its bottom line growing healthily and exceeding Wall Street’s estimate.
Limited-Time Spider-Man Offerings Available at Retail and Kellogg's New York City Café BATTLE CREEK, Mich. , June 25, 2019 /PRNewswire/ -- Kellogg's has teamed up with Sony Pictures Entertainment to help ...
Kellogg (K) is benefiting from acquisitions and a solid brand portfolio. However, the company is grappling with high cost and sluggishness in North American business unit.
Kellogg Company (NYSE: K ) announced a second restructuring program and around 150 employees In North America will be leaving as part of the reorganization. The company will take a pretax charge of about ...